Evidera
Abigail Herbst is a Research Associate III at Evidera, with extensive expertise in health research and quality improvement stemming from previous roles such as Health Science Specialist at the U.S. Department of Veterans Affairs and Graduate Research Assistant at Massachusetts General Hospital. Abigail's accomplishments include coordinating national evaluations, designing patient surveys, conducting qualitative interviews, and managing Institutional Review Board documents. Education includes a Master of Public Health from Boston University School of Public Health and a Bachelor of Arts in International Relations from Boston University. Experienced in teaching and peer mentorship, Abigail has also contributed to public health advocacy through various health education roles in community settings.
This person is not in any offices
Evidera
1 followers
Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.